Blue Trust’s Turn Therapeutics TTRX Stock Holding History
Bought
Maintained
Sold
Other funds holding TTRX
DI
Blue Trust's TTRX Position: Q3 2026 in Review
Blue Trust held its Turn Therapeutics (TTRX) position steady in Q3 2026 at 1,122 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1573.
Blue Trust first reported a position in TTRX in Q4 2025 and has held it in 4 quarters since. 36 funds tracked by Wall St. Rank hold TTRX as of Q3 2026.
- Blue Trust held 1,122 shares of Turn Therapeutics worth $16.1K as of Q3 2026.
- Blue Trust left its Turn Therapeutics share count unchanged in Q3 2026.
- Turn Therapeutics made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1573 holding.
- Blue Trust first reported a position in Turn Therapeutics in Q4 2025 and has held it in 4 quarters since.
- 36 funds tracked by Wall St. Rank held Turn Therapeutics as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.